The new Sulindac derivative IND 12 reverses Ras-induced cell transformation

Cancer Research

Volumn 62, Issue 6, 2002, Pages 1718-1723

  Karaguni, Ioanna Maria ^a   Herter, Peter ^a   Debruyne, Philip ^b   Chtarbova, Slava ^a   Kasprzynski, Alice ^a   Herbrand, Ulrike ^a   Ahmadian, M Reza ^a   Glüsenkamp, Karl Heinz ^c   Winde, Günther ^d   Mareel, Marc ^b   Möröy, Tarik ^e   Müller, Oliver ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Squarix Biotechnology GmbH   (Germany)

^d Klinikum Herford   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GUANOSINE TRIPHOSPHATASE; IND 12; MITOGEN ACTIVATED PROTEIN KINASE; RAC PROTEIN; RAF PROTEIN; RAS PROTEIN; RHO FACTOR; SULINDAC; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER THERAPY; CELL ADHESION; CELL AGGREGATION; CELL INVASION; CELL LYSATE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BETA CATENIN; CADHERINS; CELL AGGREGATION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; DOGS; ENZYME INHIBITORS; EPITHELIAL CELLS; GENES, RAS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; SULINDAC; TRANS-ACTIVATORS;

EID: 0037088262     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
2. Prevention of gastrointestinal cancer - The potential role of NSAIDs in colorectal cancer
3. Chemoprevention of colorectal cancer
4. Mechanism of action of anti-inflammatory drugs
5. Identification of the biologically active form of sulindac
6. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
7. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
8. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
9. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
10. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months
11. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
12. Sulindac sulfide inhibits Ras signaling
13. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells
14. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
15. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
16. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine
17. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
18. New indene-derivatives with anti-proliferative properties
19. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
20. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
21. V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift
22. Cell aggregation assays
23. Numerical evaluation of the invasion of closely related cell lines into collagen type I gels
24. Collagen invasion assays
25. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition
26. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase
27. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
28. Analysis of the ERK-stimulated ETS transcription factor ER81
29. Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells
30. Plasma membrane-targeted Raf kinase activates NF-κB and human immunodeficiency virus type I replication in T lymphocytes
31. Regulation of cadherin adhesive activity
32. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling